SV Health Investors Revenue and Competitors
Estimated Revenue & Valuation
- SV Health Investors's estimated annual revenue is currently $75M per year.
- SV Health Investors's estimated revenue per employee is $757,576
Employee Data
- SV Health Investors has 99 Employees.
- SV Health Investors grew their employee count by 0% last year.
SV Health Investors's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | chief administrative partne | Reveal Email/Phone |
5 | Compliance Officer | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | Partner - Finance Director / CRO | Reveal Email/Phone |
8 | Managing Partner & Chief Operating Officer | Reveal Email/Phone |
9 | Chief Financial Officer and Partner | Reveal Email/Phone |
10 | Director Finance | Reveal Email/Phone |
SV Health Investors Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $558.4M | 2693 | 0% | €3B | N/A |
What Is SV Health Investors?
SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams. SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages four funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $20m in North America and Europe, but will consider innovative investments in other regions. Our team of 28 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.
keywords:N/AN/A
Total Funding
99
Number of Employees
$75M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SV Health Investors News
The second closing includes new investor, SV Health Investors, a transatlantic venture You must be a HMI Subscriber to view this content. Login...
Prilenia Therapeutics: Houman Ashrafian, managing partner at S.V. Health Investors, co-lead of S.V.'s Biotech franchise,...
The second closing includes new investor, SV Health Investors, a leading transatlantic venture capital and growth equity firm, with offices in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.1M | 99 | 5% | N/A |
#2 | $25.1M | 99 | 13% | N/A |
#3 | $14.9M | 99 | 50% | N/A |
#4 | $15.8M | 99 | 62% | N/A |
#5 | $26.7M | 99 | -10% | N/A |